Research
The Unintended Consequences of the DOL PBM Transparency Rule: An Ode to the Little Guy (and Gal)
September 03, 2026
By Amanda Frost, PhD Vice President, Research, PCMA The law of unintended consequences, when an action produces unexpected effects outside...
Want to Understand the Prescription Drug Supply Chain? Start at the Wholesalers
August 25, 2026
By Amanda Frost, PhD Vice President, Research, PCMA Last year, the U.S. spent $1.363 trillion on prescription drugs, and every...
How the Future of GLP-1 Affordability Depends on Competition
July 29, 2026
By Amanda Frost, PhD Vice President, Research, PCMA There is no shortage of opinions these days about GLP-1 prescription drugs:...
From Flashy Ads to Expensive Drugs: 5 Things You Need to Know About Misleading Drug Advertisements
July 27, 2026
By Amanda Frost, PhD Vice President, Research, PCMA I don’t watch much television these days, but when I do, I can be assured of...
What Would You Do to Protect $50 Billion a Year?
July 22, 2026
By Amanda Frost, PhD Vice President, Research, PCMA Did you know: the original patent for semaglutide – better known as...
Missing from the VI Debate: Data That Shows It’s A Problem
June 03, 2026
By Amanda Frost, PhD Vice President, Research, PCMA Concerns about high health care costs are prevalent and appropriate, but can be often focused on the wrong place. Vertical integration (VI) is one area that is receiving attention from state and federal policymakers, with a...